Literature DB >> 26232323

Contribution of resident and recruited macrophages to the photodynamic intervention of colorectal tumor microenvironment.

María Florencia Pansa1, María Julia Lamberti1, Ingrid Sol Cogno1, Silvia Graciela Correa2, Natalia Belén Rumie Vittar1, Viviana Alicia Rivarola3.   

Abstract

The study of cellular interactions in the tumor microenvironment has become one of the main areas of research in the fight against cancer. Tumor-associated macrophages (TAMs) influence tumor progression and therapy response due to its functional plasticity. Regarding cancer treatment, photodynamic therapy (PDT) is a minimally invasive and clinically approved procedure that involves the administration of a photosensitizer (PS), a nontoxic photosensitizing drug which is selectively retained in neoplastic tissue. Here, we investigated the role of resident and nonresident macrophages in the context of a PDT-treated colorectal tumor by developing a combination of 2-D and three-dimensional (3-D) experimental platform, recreating tumor-stroma interactions in vitro. Enhancement of cytotoxicity of PDT was achieved in the presence of nonresident macrophages which had a strong anti-tumor phenotype mediated by the production of nitric oxide, IL-6, and tumor necrosis factor alpha (TNF-α). On the contrary, tumor resident macrophages induced a pro-tumor phenotype promoting tumor cell migration and endothelial stimulation. Due to their plasticity, tumor-resident or tumor-recruited macrophages can differentially influence the response of tumors to PDT, so their multifactorial roles should be considered in the overall design of anti-tumor therapeutic.

Entities:  

Keywords:  Colorectal cancer; Macrophages; Photodynamic therapy; TAMs; Tumor microenvironment

Mesh:

Substances:

Year:  2015        PMID: 26232323     DOI: 10.1007/s13277-015-3768-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  47 in total

Review 1.  Endothelial cell migration during angiogenesis.

Authors:  Laurent Lamalice; Fabrice Le Boeuf; Jacques Huot
Journal:  Circ Res       Date:  2007-03-30       Impact factor: 17.367

Review 2.  Nitric oxide synthases: roles, tolls, and controls.

Authors:  C Nathan; Q W Xie
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

3.  Green fluorescent protein as a marker for gene expression.

Authors:  M Chalfie; Y Tu; G Euskirchen; W W Ward; D C Prasher
Journal:  Science       Date:  1994-02-11       Impact factor: 47.728

4.  What can ecology teach us about cancer?

Authors:  Irina Kareva
Journal:  Transl Oncol       Date:  2011-10-01       Impact factor: 4.243

5.  Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer.

Authors:  Marco Erreni; Alberto Mantovani; Paola Allavena
Journal:  Cancer Microenviron       Date:  2010-09-17

6.  High macrophage infiltration along the tumor front correlates with improved survival in colon cancer.

Authors:  Johan Forssell; Ake Oberg; Maria L Henriksson; Roger Stenling; Andreas Jung; Richard Palmqvist
Journal:  Clin Cancer Res       Date:  2007-03-01       Impact factor: 12.531

7.  The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker.

Authors:  Rosaria Cammarota; Valentina Bertolini; Giuseppina Pennesi; Eraldo O Bucci; Ornella Gottardi; Cecilia Garlanda; Luigi Laghi; Massimo C Barberis; Fausto Sessa; Douglas M Noonan; Adriana Albini
Journal:  J Transl Med       Date:  2010-11-08       Impact factor: 5.531

8.  Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer.

Authors:  Yoshifumi Nakayama; Nobuo Nagashima; Noritaka Minagawa; Yuzuru Inoue; Takefumi Katsuki; Koji Onitsuka; Tatsuhiko Sako; Keiji Hirata; Naoki Nagata; Hideaki Itoh
Journal:  Anticancer Res       Date:  2002 Nov-Dec       Impact factor: 2.480

9.  Association of different macrophage phenotypes with infiltrating and non-infiltrating areas of tumor-host interface in colorectal carcinoma.

Authors:  S Hauptmann; G Zwadlo-Klarwasser; P Hartung; B Klosterhalfen; C J Kirkpatrick; C Mittermayer
Journal:  Pathol Res Pract       Date:  1994-02       Impact factor: 3.250

Review 10.  Immunogenic cell death: can it be exploited in PhotoDynamic Therapy for cancer?

Authors:  Elisa Panzarini; Valentina Inguscio; Luciana Dini
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

View more
  5 in total

1.  Loss of free fatty acid receptor 2 enhances colonic adenoma development and reduces the chemopreventive effects of black raspberries in ApcMin/+ mice.

Authors:  Pan Pan; Chad W Skaer; Hsin-Tzu Wang; Kiyoko Oshima; Yi-Wen Huang; Jianhua Yu; Jianying Zhang; Martha M Yearsley; Kimberle A Agle; William R Drobyski; Xiao Chen; Li-Shu Wang
Journal:  Carcinogenesis       Date:  2016-11-19       Impact factor: 4.944

2.  Bimodal Targeting Using Sulfonated, Mannosylated PEI for Combined Gene Delivery and Photodynamic Therapy.

Authors:  Upendra Chitgupi; Yi Li; Mingfu Chen; Shuai Shao; Marie Beitelshees; Myles Joshua Tan; Sriram Neelamegham; Blaine A Pfeifer; Charles Jones; Jonathan F Lovell
Journal:  Photochem Photobiol       Date:  2017-02-07       Impact factor: 3.421

3.  Inhibition of IDO leads to IL-6-dependent systemic inflammation in mice when combined with photodynamic therapy.

Authors:  Malgorzata Wachowska; Joanna Stachura; Katarzyna Tonecka; Klaudyna Fidyt; Agata Braniewska; Zuzanna Sas; Iwona Kotula; Tomasz Piotr Rygiel; Louis Boon; Jakub Golab; Angelika Muchowicz
Journal:  Cancer Immunol Immunother       Date:  2020-02-28       Impact factor: 6.968

4.  Curative effect of the recent photofrin photodynamic adjuvant treatment on young patients with advanced colorectal cancer.

Authors:  B O Sun; Wei Li; Ning Liu
Journal:  Oncol Lett       Date:  2016-02-02       Impact factor: 2.967

Review 5.  Targeting Antitumor Immune Response for Enhancing the Efficacy of Photodynamic Therapy of Cancer: Recent Advances and Future Perspectives.

Authors:  Yamin Yang; Yue Hu; Hongjun Wang
Journal:  Oxid Med Cell Longev       Date:  2016-09-08       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.